Results
73,241 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Guerre Robert PaulCorp. Sec, Dir Corp Compliance |  UFPIUFP INDUSTRIES INCGrant or award | A | $1,393 17 sh | Nov 2, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Guerre Robert PaulCorp. Sec, Dir Corp Compliance | UFPIUFP INDUSTRIES INC Grant or award | A | $1,393 17 sh | Nov 2, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner |  BBTXBambusa Therapeutics, Inc.Grant or award | A | — 379.1K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Ellerbrook Michael MPresident, UFP Construction | UFPIUFP INDUSTRIES INC Grant or award | A | $1,393 17 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel |  JBHTHUNT J B TRANSPORT SERVICES INCTax withholding | F | $43K 196 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer |  FTVFortive CorpOption exercise | M | — 5,027 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 37.4K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer | FTVFortive Corp Option exercise | M | $39K 1,017 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | DiCiollo Anthony JHead of Institutional Segment |  SNEXStoneX Group Inc.Grant or award | A | — 6,604 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Brown Kevin D.Director |  HAYWHayward Holdings, Inc.Grant or award | A | — 1,446 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 4,155 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Salvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1.47M sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | 2018 Reed Dynasty Trust10% Owner |  ARHSArhaus, Inc.Derivative conversion | C | — 192.9K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Wright Russell KeithVP and CAO |  CNPCENTERPOINT ENERGY INCTax withholding | F | $9,464 223 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Paulson JohnDirector |  BLCOBausch & Lomb CorpGrant or award | A | $23K 1,125 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $39K 177 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Gahan Patrick JosephDirector |  QMLSQumulusAI, Inc.Option exercise | M | — 11.4K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | — 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 94.0K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Mulhall Christopher M.VP - Chief Accounting Officer | FTVFortive Corp Option exercise | M | — 1,017 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | van Houte HansChief Financial Officer |  NRIXNurix Therapeutics, Inc.Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Mottola FrankSVP, Chief Tech. Ops. Officer |  SUPNSUPERNUS PHARMACEUTICALS, INC.Grant or award | A | — 100.0K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $34K 11.4K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $601 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Tax withholding | F | $48K 219 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | Tarvin Landon CPresident, UFP Retail | UFPIUFP INDUSTRIES INC Grant or award | A | $1,147 14 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 15.8K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Rhymes Michael AnthonyDirector |  SHENSHENANDOAH TELECOMMUNICATIONS CO/VA/Grant or award | A | $500 49 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Alfonso EduardoDirector | BLCOBausch & Lomb Corp Grant or award | A | $23K 1,125 sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1,753 sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 10.4K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Cooper Diane L.Director | SNEXStoneX Group Inc. Grant or award | A | — 164 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Boattini JenniferSR VP Legal/General Counsel | JBHTHUNT J B TRANSPORT SERVICES INC Option exercise | M | — 434 sh | Nov 2, 2026 traded Oct 31, 2026 |
| 9 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Xu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 16.4K sh | Nov 2, 2026 traded Nov 2, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | — 24.4K sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | 2018 Reed Dynasty Trust10% Owner | ARHSArhaus, Inc. Derivative conversion | C | — 192.9K sh | Nov 2, 2026 traded Oct 29, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | $14K 4,740 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Gahan Patrick JosephDirector | QMLSQumulusAI, Inc. Option exercise | M | $601 182 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 9 | Krosnowski Scott CarrollChief Financial Officer | QMLSQumulusAI, Inc. Option exercise | M | — 33.3K sh | Nov 2, 2026 traded Oct 30, 2026 |